These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 22291646)

  • 1. Chronic administration of a leupeptin-derived calpain inhibitor fails to ameliorate severe muscle pathology in a canine model of duchenne muscular dystrophy.
    Childers MK; Bogan JR; Bogan DJ; Greiner H; Holder M; Grange RW; Kornegay JN
    Front Pharmacol; 2011; 2():89. PubMed ID: 22291646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Golden retriever muscular dystrophy (GRMD): Developing and maintaining a colony and physiological functional measurements.
    Kornegay JN; Bogan JR; Bogan DJ; Childers MK; Grange RW
    Methods Mol Biol; 2011; 709():105-23. PubMed ID: 21194024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prednisone in canine muscular dystrophy.
    Liu JM; Okamura CS; Bogan DJ; Bogan JR; Childers MK; Kornegay JN
    Muscle Nerve; 2004 Dec; 30(6):767-73. PubMed ID: 15468337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide association study to identify potential genetic modifiers in a canine model for Duchenne muscular dystrophy.
    Brinkmeyer-Langford C; Balog-Alvarez C; Cai JJ; Davis BW; Kornegay JN
    BMC Genomics; 2016 Aug; 17(1):665. PubMed ID: 27549615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural History of Cardiomyopathy in Adult Dogs With Golden Retriever Muscular Dystrophy.
    Guo LJ; Soslow JH; Bettis AK; Nghiem PP; Cummings KJ; Lenox MW; Miller MW; Kornegay JN; Spurney CF
    J Am Heart Assoc; 2019 Aug; 8(16):e012443. PubMed ID: 31411085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eccentric contraction injury in dystrophic canine muscle.
    Childers MK; Okamura CS; Bogan DJ; Bogan JR; Petroski GF; McDonald K; Kornegay JN
    Arch Phys Med Rehabil; 2002 Nov; 83(11):1572-8. PubMed ID: 12422328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Targeted Metabolomics Analysis of Golden Retriever Muscular Dystrophy-Affected Muscles Reveals Alterations in Arginine and Proline Metabolism, and Elevations in Glutamic and Oleic Acid In Vivo.
    Abdullah M; Kornegay JN; Honcoop A; Parry TL; Balog-Alvarez CJ; O'Neal SK; Bain JR; Muehlbauer MJ; Newgard CB; Patterson C; Willis MS
    Metabolites; 2017 Jul; 7(3):. PubMed ID: 28758940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystrophin-deficient dogs with reduced myostatin have unequal muscle growth and greater joint contractures.
    Kornegay JN; Bogan DJ; Bogan JR; Dow JL; Wang J; Fan Z; Liu N; Warsing LC; Grange RW; Ahn M; Balog-Alvarez CJ; Cotten SW; Willis MS; Brinkmeyer-Langford C; Zhu H; Palandra J; Morris CA; Styner MA; Wagner KR
    Skelet Muscle; 2016; 6():14. PubMed ID: 27047655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A computerized MRI biomarker quantification scheme for a canine model of Duchenne muscular dystrophy.
    Wang J; Fan Z; Vandenborne K; Walter G; Shiloh-Malawsky Y; An H; Kornegay JN; Styner MA
    Int J Comput Assist Radiol Surg; 2013 Sep; 8(5):763-74. PubMed ID: 23299128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy.
    Kornegay JN; Peterson JM; Bogan DJ; Kline W; Bogan JR; Dow JL; Fan Z; Wang J; Ahn M; Zhu H; Styner M; Guttridge DC
    Skelet Muscle; 2014; 4():18. PubMed ID: 25789154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.
    Kornegay JN; Bogan JR; Bogan DJ; Childers MK; Li J; Nghiem P; Detwiler DA; Larsen CA; Grange RW; Bhavaraju-Sanka RK; Tou S; Keene BP; Howard JF; Wang J; Fan Z; Schatzberg SJ; Styner MA; Flanigan KM; Xiao X; Hoffman EP
    Mamm Genome; 2012 Feb; 23(1-2):85-108. PubMed ID: 22218699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiling of disease progression in canine model of Duchenne muscular dystrophy.
    Brinkmeyer-Langford C; Chu C; Balog-Alvarez C; Yu X; Cai JJ; Nabity M; Kornegay JN
    PLoS One; 2018; 13(3):e0194485. PubMed ID: 29554127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy.
    Schneider SM; Sridhar V; Bettis AK; Heath-Barnett H; Balog-Alvarez CJ; Guo LJ; Johnson R; Jaques S; Vitha S; Glowcwski AC; Kornegay JN; Nghiem PP
    Mol Imaging Biol; 2018 Oct; 20(5):780-788. PubMed ID: 29508262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term treatment of golden retriever muscular dystrophy (GRMD) dogs with rAAVrh74.MHCK7.GALGT2 induces muscle glycosylation and utrophin expression but has no significant effect on muscle strength.
    Martin PT; Zygmunt DA; Ashbrook A; Hamilton S; Packer D; Birch SM; Bettis AK; Balog-Alvarez CJ; Guo LJ; Nghiem PP; Kornegay JN
    PLoS One; 2021; 16(3):e0248721. PubMed ID: 33770101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired autophagy correlates with golden retriever muscular dystrophy phenotype.
    Stoughton WB; Li J; Balog-Alvarez C; Kornegay JN
    Muscle Nerve; 2018 Sep; 58(3):418-426. PubMed ID: 29513363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural History of Histopathologic Changes in Cardiomyopathy of Golden Retriever Muscular Dystrophy.
    Schneider SM; Sansom GT; Guo LJ; Furuya S; Weeks BR; Kornegay JN
    Front Vet Sci; 2021; 8():759585. PubMed ID: 35252412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of the six-minute walk test to characterize golden retriever muscular dystrophy.
    Acosta AR; Van Wie E; Stoughton WB; Bettis AK; Barnett HH; LaBrie NR; Balog-Alvarez CJ; Nghiem PP; Cummings KJ; Kornegay JN
    Neuromuscul Disord; 2016 Dec; 26(12):865-872. PubMed ID: 27818009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological comparison of the smooth uterine muscle of healthy golden retriever bitches, carriers of the progressive muscular dystrophy (GRMD) gene, and GRMD-affected bitches.
    Brolio MP; Cima DS; Miglino MA; Ambrósio CE
    Anim Reprod Sci; 2014 Nov; 150(1-2):56-61. PubMed ID: 25200710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic myostatin decrease in the golden retriever muscular dystrophy model does not significantly affect the ubiquitin proteasome system despite enhancing the severity of disease.
    Cotten SW; Kornegay JN; Bogan DJ; Wadosky KM; Patterson C; Willis MS
    Am J Transl Res; 2013; 6(1):43-53. PubMed ID: 24349620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.